Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing.

apnea glycated hemoglobin hypopnea obstructive sleep apnea prediabetes

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 27 01 2022
revised: 24 02 2022
accepted: 02 03 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Type 2 diabetes leads to severe nocturnal hypoxemia, with an increase in apnea events and daytime sleepiness. Hence, we assessed sleep breathing parameters in the prediabetes stage. A cross-sectional study conducted on 966 middle-aged subjects without known pulmonary disease (311 patients with prediabetes and 655 controls with normal glucose metabolism) was conducted. Prediabetes was defined by glycated hemoglobin (HbA1c), and a nonattended overnight home sleep study was performed. Participants with prediabetes (n = 311) displayed a higher apnea−hypopnea index (AHI: 12.7 (6.1;24.3) vs. 9.5 (4.2;19.6) events/h, p < 0.001) and hypopnea index (HI: 8.4 (4.0;14.9) vs. 6.0 (2.7;12.6) events/h, p < 0.001) than controls, without differences in the apnea index. Altogether, the prevalence of obstructive sleep apnea was higher in subjects with prediabetes than in controls (78.1 vs. 69.9%, p = 0.007). Additionally, subjects with prediabetes presented impaired measurements of the median and minimum nocturnal oxygen saturation, the percentage of time spent with oxygen saturations below 90%, and the 4% oxygen desaturation index in comparison with individuals without prediabetes (p < 0.001 for all). After adjusting for age, sex, and the presence of obesity, HbA1c correlated with the HI in the entire population (r = 0.141, p < 0.001), and the presence of prediabetes was independently associated with the AHI (B = 2.20 (0.10 to 4.31), p = 0.040) as well as the HI (B = 1.87 (0.61 to 3.14), p = 0.004) in the multiple linear regression model. We conclude that prediabetes is an independent risk factor for an increased AHI after adjusting for age, sex, and obesity. The enhanced AHI is mainly associated with increments in the hypopnea events.

Identifiants

pubmed: 35268504
pii: jcm11051413
doi: 10.3390/jcm11051413
pmc: PMC8910907
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Lleida Provincial Council, Autonomous Government of Catalonia
ID : 2017SGR696 and SLT0021600250
Organisme : Instituto de Salud Carlos III
ID : PI12/00803, PI15/00260 and PI18/00964

Références

PLoS One. 2015 Mar 11;10(3):e0119073
pubmed: 25760760
J Clin Sleep Med. 2007 Jun 15;3(4):387-92
pubmed: 17694728
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S25-8
pubmed: 10997603
Int J Endocrinol. 2012;2012:902324
pubmed: 22829819
PLoS One. 2009;4(3):e4692
pubmed: 19262746
Psychoneuroendocrinology. 2019 Dec;110:104444
pubmed: 31546116
Int J Obes (Lond). 2016 Aug;40(8):1310-9
pubmed: 27005405
J Physiol. 2016 Mar 15;594(6):1617-25
pubmed: 26095748
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Diabetes Care. 2010 May;33(5):1044-9
pubmed: 20185739
Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24
pubmed: 27979889
Cardiovasc Diabetol. 2011 Sep 25;10:84
pubmed: 21943153
Ann Am Thorac Soc. 2016 Aug;13(8):1378-87
pubmed: 27104640
Diabetes Care. 2020 May;43(5):1126-1133
pubmed: 32161051
Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3429-33
pubmed: 27207142
Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1042-1053
pubmed: 33162389
Obesity (Silver Spring). 2007 Jun;15(6):1409-18
pubmed: 17557978
J Clin Med. 2020 Apr 04;9(4):
pubmed: 32260419
Diabetes Res Clin Pract. 2008 Jul;81(1):2-12
pubmed: 18544448
Diabetes Care. 2018 Oct;41(10):2111-2119
pubmed: 30072403
BMJ Open. 2017 Dec 22;7(12):e013983
pubmed: 29275335
PLoS One. 2016 Jun 17;11(6):e0157579
pubmed: 27315083
Clin Chem. 2014 Aug;60(8):1062-72
pubmed: 24865164
J Clin Endocrinol Metab. 2001 Feb;86(2):517-20
pubmed: 11158002
J Clin Sleep Med. 2017 Mar 15;13(3):479-504
pubmed: 28162150
Nefrologia. 2016 Jul-Aug;36(4):389-96
pubmed: 27044887
Lancet. 2009 Jan 3;373(9657):82-93
pubmed: 19101028
PLoS One. 2013 Apr 17;8(4):e61382
pubmed: 23613841
Eur Respir J. 2009 Jul;34(1):243-60
pubmed: 19567607
Chest. 2017 Nov;152(5):1070-1086
pubmed: 28527878
Nat Sci Sleep. 2018 Jan 23;10:21-34
pubmed: 29416383
J Sleep Res. 2017 Dec;26(6):756-763
pubmed: 28560837
PLoS One. 2019 Feb 5;14(2):e0211742
pubmed: 30721271
Diabet Med. 2017 Jan;34(1):79-85
pubmed: 27278263
Diabetes Res Clin Pract. 2005 Jan;67(1):84-91
pubmed: 15620438
Nutr Diabetes. 2019 Nov 4;9(1):32
pubmed: 31685792
Endocr Rev. 2017 Dec 1;38(6):550-573
pubmed: 28938479
Cardiovasc Diabetol. 2019 Nov 15;18(1):154
pubmed: 31729979

Auteurs

Enric Sánchez (E)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Obesity, Diabetes and Metabolism (ODIM) Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
University of Lleida, 25003 Lleida, Spain.

Esther Sapiña-Beltrán (E)

University of Lleida, 25003 Lleida, Spain.
Respiratory Department, University Hospital Arnau de Vilanova and Santa María, 25198 Lleida, Spain.
Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Ricard Gavaldà (R)

Amalfi Analytics, Polytechnic University of Catalonia, 08034 Barcelona, Spain.

Ferran Barbé (F)

University of Lleida, 25003 Lleida, Spain.
Respiratory Department, University Hospital Arnau de Vilanova and Santa María, 25198 Lleida, Spain.
Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Gerard Torres (G)

University of Lleida, 25003 Lleida, Spain.
Respiratory Department, University Hospital Arnau de Vilanova and Santa María, 25198 Lleida, Spain.
Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Ariadna Sauret (A)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.

Mireia Dalmases (M)

University of Lleida, 25003 Lleida, Spain.
Respiratory Department, University Hospital Arnau de Vilanova and Santa María, 25198 Lleida, Spain.
Group of Translational Research in Respiratory Medicine, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Carolina López-Cano (C)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Obesity, Diabetes and Metabolism (ODIM) Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
University of Lleida, 25003 Lleida, Spain.

Liliana Gutiérrez-Carrasquilla (L)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Obesity, Diabetes and Metabolism (ODIM) Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
University of Lleida, 25003 Lleida, Spain.

Marcelino Bermúdez-López (M)

Vascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Red de Investigación Renal, Instituto de Salud Carlos III (RedinRen-ISCIII), 28029 Madrid, Spain.

Elvira Fernández (E)

Vascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Red de Investigación Renal, Instituto de Salud Carlos III (RedinRen-ISCIII), 28029 Madrid, Spain.

Francisco Purroy (F)

University of Lleida, 25003 Lleida, Spain.
Stroke Unit, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Clinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.

Eva Castro-Boqué (E)

Vascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Red de Investigación Renal, Instituto de Salud Carlos III (RedinRen-ISCIII), 28029 Madrid, Spain.

Cristina Farràs-Sallés (C)

Applied Epidemiology Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Lleida Research Support Unit, Jordi Gol i Gurina University Institute for Research in Primary Health Care (IDIAPJGol), 25007 Lleida, Spain.

Reinald Pamplona (R)

University of Lleida, 25003 Lleida, Spain.
Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.

Dídac Mauricio (D)

Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Sant Pau Biomedical Research Institute (IIB Sant Pau), 08041 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Grupo de Investigación Epidemiológica en Diabetes des de Atención Primaria (DAP_Cat Group), Unitat de Suport a la Recerca de Barcelona, Jordi Gol i Gurina University Institute for Research in Primary Health Care (IDIAPJGol), 08007 Barcelona, Spain.

Cristina Hernández (C)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Endocrinology and Nutrition Department, University Hospital Vall d'Hebron, 08024 Barcelona, Spain.
Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08024 Barcelona, Spain.
Autonomous University of Barcelona, 08024 Barcelona, Spain.

Rafael Simó (R)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Endocrinology and Nutrition Department, University Hospital Vall d'Hebron, 08024 Barcelona, Spain.
Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08024 Barcelona, Spain.
Autonomous University of Barcelona, 08024 Barcelona, Spain.

Albert Lecube (A)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Obesity, Diabetes and Metabolism (ODIM) Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
University of Lleida, 25003 Lleida, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Classifications MeSH